tuneTypical Dose
Trial protocols vary too much across prevention, immune-marker, and inflammatory contexts for one confident generic recommendation
Fatty Acid
Black Currant Seed Oil
Ribes nigrum
Evidence TierDWADA NOT PROHIBITED
watchEffect Window
The limited trials assessed outcomes over weeks to months rather than days.
check_circleCompliance
WADA NOT PROHIBITED
Overview
Clinical Summary
Black currant seed oil has small, old, low-confidence human signals in atopy and inflammatory conditions, but the evidence is too thin for broad skin or immune-support claims.
Black currant seed oil is marketed for skin barrier support, inflammatory balance, immune health, and general omega support. The human evidence is much narrower and weaker than that positioning suggests. A few older trials report transient atopy-related or immune-marker benefits, and one older rheumatoid-arthritis trial showed mixed results. That is enough for a low-confidence record, not for strong claims.
Black currant seed oil supplies gamma-linolenic acid, alpha-linolenic acid, and related fatty acids that may affect eicosanoid balance and inflammatory signaling. The mechanistic story is plausible, but the clinical translation remains thin and low confidence.
Outcomes
What This Is Expected To Influence
Primary Outcomes
- Low-confidence atopy or skin-related signal in early-life prevention settings
Secondary Outcomes
- Low-confidence immune-marker effects
- Weak and inconsistent anti-inflammatory clinical evidence
Safety
Contraindications and Interactions
Contraindications
- Relevant berry or seed-oil intolerance
Side effects
- Mild GI upset
Interactions
- Anticoagulant or antiplatelet strategies
Avoid if
- You are using it for broad immune or inflammatory claims
- The product quality or freshness is uncertain
Evidence
Study-level References
bcso-SRC-001Randomized controlled trial
Sourceopen_in_newLinnamaa P, Savolainen J, Koulu L, et al. Blackcurrant seed oil for prevention of atopic dermatitis in newborns. A randomized, double-blind, placebo-controlled trial. Clin Exp Allergy. 2010;40(8):1247-1255. doi:10.1111/j.1365-2222.2010.03540.x. PMID:20545710.
Population: Pregnant mothers and infants at increased atopy risk because of high parental atopy prevalence.
Dose protocol: Maternal and infant supplementation through pregnancy, breastfeeding, and infancy
Key findings: Lower atopic-dermatitis prevalence and severity at 12 months, but not clearly sustained at 24 months.
Notes: Interesting prevention study, but not a general adult-use trial.
Paper content
This trial is one of the more relevant direct human studies for blackcurrant seed oil, but it is still a niche prevention study in infants at high atopy risk rather than a general supplement-efficacy trial for adults. It showed a transient reduction in atopic dermatitis prevalence and severity at 12 months, with no clear difference by 24 months. That supports only very narrow, low-confidence skin or atopy framing.
bcso-SRC-002Randomized controlled trial
Sourceopen_in_newWu D, Meydani M, Leka LS, et al. Effect of dietary supplementation with black currant seed oil on the immune response of healthy elderly subjects. Am J Clin Nutr. 1999;70(4):536-543. doi:10.1093/ajcn/70.4.536. PMID:10500023.
Population: Healthy adults aged 65 years and older.
Dose protocol: 2 months of supplementation in healthy elderly adults
Key findings: Changed some immune-response markers and reduced prostaglandin E2 production.
Notes: Surrogate immune endpoints only.
Paper content
This older trial is one of the reasons black currant seed oil gets immune-support marketing, but the outcomes are immunologic surrogates rather than clinical disease endpoints. It suggests that the oil can alter some immune-response measures in older adults, but it does not establish that supplementation prevents infection or meaningfully improves everyday immune health.
bcso-SRC-003Randomized controlled trial
Sourceopen_in_newLeventhal LJ, Boyce EG, Zurier RB. Treatment of rheumatoid arthritis with blackcurrant seed oil. Br J Rheumatol. 1994;33(9):847-852. PMID:8081671.
Population: Adults with rheumatoid arthritis and active synovitis.
Dose protocol: 15 capsules daily for 24 weeks
Key findings: Mixed rheumatoid-arthritis symptom findings without clear strong overall superiority to placebo.
Notes: Too weak and cumbersome for strong anti-inflammatory claims.
Paper content
This rheumatoid arthritis trial is the best direct anti-inflammatory clinical signal for blackcurrant seed oil, but it is still weak. Some disease-activity measures improved, yet overall clinical response was not clearly superior to placebo by the study’s own stricter framing, and the intervention required a very large capsule burden. That makes it an interesting signal, not a convincing anti-inflammatory use case.
bcso-SRC-004Randomized, triple-blind, placebo-controlled, parallel trial
Sourceopen_in_newNiseteo T, Hojsak I, Ozanic Bulic S, Pustisek N. Effect of Omega-3 Polyunsaturated Fatty Acid Supplementation on Clinical Outcome of Atopic Dermatitis in Children. Nutrients. 2024;16(17):2829. doi:10.3390/nu16172829. PMID:39275147.
Population: Children with atopic dermatitis.
Dose protocol: Omega-3 from fish oil combined with GLA from blackcurrant seed oil plus vitamin D for 4 months in 52 children with AD.
Key findings: SCORAD decreased from median 42 to 25 (P<0.001). Topical corticosteroid use dropped from 30 to 10 mg/month (P<0.001).
Notes: Combination product limits attribution to blackcurrant seed oil alone. Adds a modern pediatric AD data point consistent with the GLA anti-inflammatory rationale.
Paper content
This triple-blind RCT in 52 children with atopic dermatitis found that 4 months of a combined supplement containing omega-3 from fish oil, GLA from blackcurrant seed oil, and vitamin D significantly reduced SCORAD severity scores (from median 42 to 25) and topical corticosteroid use (from 30 to 10 mg/month) compared to placebo. The combination product makes it difficult to attribute effects to blackcurrant seed oil alone, but the inclusion of GLA from blackcurrant seed oil aligns with its proposed anti-inflammatory fatty acid mechanism in atopic conditions.